Title : A randomized, placebo-controlled study investigating the nicotinic alpha7 agonist, RG3487, for cognitive deficits in schizophrenia - Umbricht_2014_Neuropsychopharmacology_39_1568 |
Author(s) : Umbricht D , Keefe RS , Murray S , Lowe DA , Porter R , Garibaldi G , Santarelli L |
Ref : Neuropsychopharmacology , 39 :1568 , 2014 |
Abstract : Umbricht_2014_Neuropsychopharmacology_39_1568 |
ESTHER : Umbricht_2014_Neuropsychopharmacology_39_1568 |
PubMedSearch : Umbricht_2014_Neuropsychopharmacology_39_1568 |
PubMedID: 24549101 |
Umbricht D, Keefe RS, Murray S, Lowe DA, Porter R, Garibaldi G, Santarelli L (2014)
A randomized, placebo-controlled study investigating the nicotinic alpha7 agonist, RG3487, for cognitive deficits in schizophrenia
Neuropsychopharmacology
39 :1568
Umbricht D, Keefe RS, Murray S, Lowe DA, Porter R, Garibaldi G, Santarelli L (2014)
Neuropsychopharmacology
39 :1568